FLUVOXAMINE MALEATE

FLUVOXAMINE MALEATE was reported 2437 times

FLUVOXAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EARLY ONSET PRIMARY DYSTONIA 3 0.2500
1 EXTRINSIC VASCULAR COMPRESSION 2 0.1818
2 MEIGE'S SYNDROME 3 0.0811
3 MYOGLOBIN URINE PRESENT 16 0.0650
4 DERMATITIS ARTEFACTA 2 0.0556
5 CONGENITAL ACROCHORDON 3 0.0462
6 LABELLED DRUG-FOOD INTERACTION ISSUE 7 0.0412
7 NASAL FLARING 5 0.0370
8 CONGENITAL NAEVUS 5 0.0352
9 BLADDER DISTENSION 3 0.0238
10 COMA BLISTER 2 0.0222
11 SIDEROBLASTIC ANAEMIA 3 0.0214
12 ACTIVATION SYNDROME 7 0.0202
13 PRODUCT ADMINISTRATION ISSUE 4 0.0191
14 MICROVASCULAR CORONARY ARTERY DISEASE 4 0.0186
15 FACIAL DYSMORPHISM 4 0.0181
16 NEONATAL BEHAVIOURAL SYNDROME 5 0.0163
17 GAMMA-GLUTAMYLTRANSFERASE DECREASED 3 0.0156
18 CYANOSIS CENTRAL 4 0.0154
19 DELUSION OF REFERENCE 2 0.0144
20 POSITIVE AIRWAY PRESSURE THERAPY 4 0.0137
21 CONGENITAL HEARING DISORDER 2 0.0123
22 CYCLOTHYMIC DISORDER 2 0.0122
23 USE OF ACCESSORY RESPIRATORY MUSCLES 5 0.0121
24 CYSTIC LYMPHANGIOMA 2 0.0116
25 ANAEMIA FOLATE DEFICIENCY 2 0.0104
26 DEAFNESS CONGENITAL 2 0.0100
27 BLOOD OSMOLARITY INCREASED 3 0.0091
28 NEONATAL RESPIRATORY DEPRESSION 3 0.0090
29 ALDOLASE INCREASED 2 0.0088
30 CEREBELLAR ATROPHY 7 0.0079
31 DRUG INTERACTION POTENTIATION 2 0.0078
32 DELAYED RECOVERY FROM ANAESTHESIA 7 0.0074
33 GASTROINTESTINAL HYPERMOTILITY 3 0.0070
34 ASPIRATION BRONCHIAL 2 0.0068
35 EAR MALFORMATION 3 0.0065
36 MICROGNATHIA 3 0.0060
37 WRONG PATIENT 3 0.0060
38 CONGENITAL HYDROCEPHALUS 3 0.0059
39 VISCERAL CONGESTION 3 0.0059
40 GIARDIASIS 2 0.0059
41 BRUGADA SYNDROME 6 0.0058
42 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 4 0.0058
43 ANTIPSYCHOTIC DRUG LEVEL INCREASED 16 0.0057
44 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 5 0.0056
45 MULTIPLE DRUG OVERDOSE INTENTIONAL 18 0.0056
46 DISINHIBITION 9 0.0056
47 BIPOLAR II DISORDER 2 0.0056
48 KERATOCONUS 2 0.0053
49 NEONATAL RESPIRATORY DISTRESS 5 0.0053
50 MOANING 6 0.0053
51 NEGATIVISM 4 0.0053
52 ALKALOSIS 2 0.0052
53 PYELOCALIECTASIS 5 0.0052
54 OBSESSIVE-COMPULSIVE DISORDER 41 0.0051
55 LONG QT SYNDROME 12 0.0050
56 BRONCHITIS ACUTE 2 0.0050
57 DELIRIUM TREMENS 2 0.0050
58 PITTING OEDEMA 3 0.0049
59 HYPOXIC ENCEPHALOPATHY 2 0.0049
60 BLOOD OSMOLARITY DECREASED 3 0.0048
61 JOINT SPRAIN 5 0.0048
62 FRONTOTEMPORAL DEMENTIA 2 0.0047
63 ELEVATED MOOD 2 0.0046
64 SEROTONIN SYNDROME 81 0.0042
65 CEREBELLAR ATAXIA 4 0.0042
66 SOFT TISSUE INJURY 3 0.0040
67 BLOOD FIBRINOGEN INCREASED 3 0.0038
68 CONVULSION NEONATAL 2 0.0038
69 ELECTROMECHANICAL DISSOCIATION 3 0.0038
70 SELF INJURIOUS BEHAVIOUR 11 0.0036
71 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 4 0.0036
72 AMYLASE INCREASED 13 0.0035
73 ENANTHEMA 2 0.0035
74 ENTERAL NUTRITION 2 0.0034
75 OBSESSIVE THOUGHTS 6 0.0033
76 BLOOD UREA DECREASED 4 0.0032
77 HEPATIC CONGESTION 3 0.0032
78 TOXIC ENCEPHALOPATHY 16 0.0032
79 HYPOGLYCAEMIA NEONATAL 5 0.0031
80 TONIC CLONIC MOVEMENTS 4 0.0031
81 COMPULSIONS 2 0.0030
82 AREFLEXIA 8 0.0030
83 POTENTIATING DRUG INTERACTION 10 0.0030
84 LYMPHOCYTIC INFILTRATION 3 0.0030
85 BRADYPNOEA 8 0.0030
86 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 2 0.0029
87 GENITAL HYPOAESTHESIA 3 0.0029
88 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
89 TORTICOLLIS 6 0.0028
90 NEUROLEPTIC MALIGNANT SYNDROME 33 0.0028
91 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
92 APALLIC SYNDROME 2 0.0028
93 CLONIC CONVULSION 2 0.0027
94 GASTRITIS HAEMORRHAGIC 4 0.0027
95 INDIFFERENCE 2 0.0027
96 HYPERREFLEXIA 9 0.0026
97 LABORATORY TEST INTERFERENCE 2 0.0025
98 CHRONIC HEPATITIS 2 0.0025
99 IMPULSIVE BEHAVIOUR 9 0.0024
100 DENTAL DISCOMFORT 2 0.0024
101 GAZE PALSY 4 0.0023
102 PERSONALITY DISORDER 6 0.0023
103 KYPHOSIS 4 0.0023
104 ENURESIS 9 0.0022
105 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
106 DRUG TOXICITY 30 0.0022
107 GALACTORRHOEA 14 0.0022
108 ABULIA 2 0.0022
109 CONGESTIVE CARDIOMYOPATHY 9 0.0022
110 CHRONIC FATIGUE SYNDROME 3 0.0022
111 TONIC CONVULSION 3 0.0021
112 ANXIETY DISORDER 7 0.0021
113 BLOOD URINE 2 0.0021
114 BONE MARROW DEPRESSION 2 0.0020
115 DIFFICULTY IN WALKING 7 0.0020
116 EXCESSIVE EYE BLINKING 3 0.0020
117 MULTIPLE DRUG OVERDOSE 10 0.0020
118 PERSECUTORY DELUSION 5 0.0020
119 METABOLIC ENCEPHALOPATHY 6 0.0020
120 TROPONIN INCREASED 15 0.0020
121 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
122 ACUTE PROMYELOCYTIC LEUKAEMIA 2 0.0019
123 HYPOTONIA NEONATAL 3 0.0019
124 BLOOD CREATINE PHOSPHOKINASE INCREASED 55 0.0019
125 CATATONIA 10 0.0019
126 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
127 ANTICHOLINERGIC SYNDROME 3 0.0019
128 INFUSION SITE BRUISING 4 0.0019
129 BLADDER DILATATION 2 0.0018
130 CLONUS 5 0.0018
131 METABOLIC SYNDROME 3 0.0018
132 CEREBELLAR SYNDROME 4 0.0018
133 COMPLEX PARTIAL SEIZURES 2 0.0018
134 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
135 TORSADE DE POINTES 14 0.0018
136 MUSCLE RIGIDITY 21 0.0018
137 GRANULOCYTOPENIA 10 0.0018
138 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
139 TACHYPHRENIA 6 0.0017
140 HYPERTONIC BLADDER 5 0.0017
141 DEPRESSIVE SYMPTOM 6 0.0017
142 INTRUSIVE THOUGHTS 2 0.0017
143 BRADYKINESIA 10 0.0017
144 AKATHISIA 23 0.0017
145 SCHIZOAFFECTIVE DISORDER 3 0.0017
146 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
147 NARCOLEPSY 3 0.0016
148 INFUSION SITE PRURITUS 5 0.0016
149 HOSTILITY 4 0.0016
150 DRUG LEVEL INCREASED 26 0.0016
151 BIPOLAR DISORDER 17 0.0016
152 INFUSION SITE IRRITATION 2 0.0016
153 STUPOR 5 0.0016
154 BLOOD CHLORIDE DECREASED 4 0.0015
155 SKIN WARM 9 0.0015
156 CALCIUM DEFICIENCY 2 0.0015
157 ADJUSTMENT DISORDER 2 0.0015
158 ANAEMIA POSTOPERATIVE 2 0.0015
159 FEELING GUILTY 2 0.0015
160 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
161 SOPOR 20 0.0015
162 MYOCLONUS 18 0.0015
163 THERAPEUTIC AGENT TOXICITY 5 0.0015
164 TIC 8 0.0015
165 CLUSTER HEADACHE 2 0.0015
166 DRUG INTERACTION 230 0.0014
167 DEATH NEONATAL 2 0.0014
168 LOGORRHOEA 5 0.0014
169 CATAPLEXY 2 0.0014
170 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
171 DEREALISATION 3 0.0014
172 INTENTIONAL SELF-INJURY 28 0.0014
173 JUDGEMENT IMPAIRED 2 0.0014
174 DIABETES MELLITUS NON-INSULIN-DEPENDENT 2 0.0014
175 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
176 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
177 SUICIDE ATTEMPT 83 0.0014
178 BIPOLAR I DISORDER 3 0.0014
179 HYPERTHERMIA MALIGNANT 2 0.0013
180 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
181 FEAR OF DEATH 3 0.0013
182 MYDRIASIS 17 0.0013
183 SCHIZOPHRENIA 16 0.0013
184 ACCIDENTAL DRUG INTAKE BY CHILD 2 0.0013
185 SALIVARY HYPERSECRETION 13 0.0013
186 AFFECTIVE DISORDER 10 0.0013
187 SLOW SPEECH 3 0.0012
188 HOMICIDAL IDEATION 5 0.0012
189 POSTURE ABNORMAL 4 0.0012
190 CARDIAC FAILURE ACUTE 8 0.0012
191 GRAND MAL CONVULSION 11 0.0012
192 EXCORIATION 3 0.0012
193 EROSIVE OESOPHAGITIS 2 0.0012
194 BUNDLE BRANCH BLOCK LEFT 5 0.0012
195 ELECTROCARDIOGRAM QT PROLONGED 42 0.0012
196 CERVICAL SPINAL STENOSIS 2 0.0012
197 SUICIDAL IDEATION 103 0.0011
198 CONJUNCTIVAL HYPERAEMIA 4 0.0011
199 ILEUS PARALYTIC 5 0.0011
200 BODY TEMPERATURE DECREASED 11 0.0011
201 BLOOD SODIUM INCREASED 3 0.0011
202 ANORGASMIA 3 0.0011
203 HYPOMANIA 4 0.0011
204 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
205 SNORING 4 0.0011
206 HYPOPROTEINAEMIA 2 0.0011
207 HYPERTHERMIA 8 0.0010
208 HYPERTONIA 6 0.0010
209 INTENTIONAL MISUSE 2 0.0010
210 BLOOD POTASSIUM INCREASED 17 0.0010
211 VOMITING PROJECTILE 3 0.0010
212 ABORTION 3 0.0010
213 POLYDIPSIA 4 0.0010
214 HEPATITIS FULMINANT 3 0.0010
215 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
216 CEREBROVASCULAR DISORDER 3 0.0010
217 HIV INFECTION 3 0.0010
218 CRANIOCEREBRAL INJURY 3 0.0010
219 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
220 INTRAMEDULLARY ROD INSERTION 2 0.0010
221 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
222 DIVERTICULAR PERFORATION 2 0.0010
223 AKINESIA 2 0.0010
224 PRE-EXISTING CONDITION IMPROVED 6 0.0010
225 RESTLESSNESS 35 0.0010
226 SELF-INJURIOUS IDEATION 4 0.0010
227 HAEMODIALYSIS 8 0.0010
228 DRUG EFFECT INCREASED 3 0.0009
229 PSYCHIATRIC SYMPTOM 7 0.0009
230 HYPERKINESIA 2 0.0009
231 CARDIAC FAILURE CHRONIC 4 0.0009
232 PARANOIA 16 0.0009
233 PARKINSONISM 9 0.0009
234 BRADYPHRENIA 6 0.0009
235 INFUSION SITE HAEMORRHAGE 3 0.0009
236 DIABETIC NEPHROPATHY 2 0.0009
237 COLONOSCOPY 2 0.0009
238 COMPLETED SUICIDE 75 0.0009
239 ADENOCARCINOMA 2 0.0009
240 URINE ABNORMALITY 4 0.0009
241 DEPRESSION SUICIDAL 3 0.0009
242 FLAT AFFECT 2 0.0009
243 THROMBOPHLEBITIS 3 0.0009
244 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
245 HAEMORRHAGIC DIATHESIS 3 0.0008
246 EOSINOPHIL COUNT DECREASED 2 0.0008
247 HYPOVOLAEMIC SHOCK 4 0.0008
248 GUILLAIN-BARRE SYNDROME 4 0.0008
249 MONOCYTE COUNT INCREASED 3 0.0008
250 MAJOR DEPRESSION 6 0.0008
251 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
252 DEVICE INFUSION ISSUE 2 0.0008
253 NEURODERMATITIS 3 0.0008
254 STATUS EPILEPTICUS 9 0.0008
255 PROTEIN TOTAL DECREASED 3 0.0008
256 MANIA 13 0.0008
257 ABDOMINAL INFECTION 2 0.0008
258 ABNORMAL UTERINE BLEEDING 2 0.0008
259 ANOREXIA 10 0.0008
260 PANIC DISORDER 3 0.0008
261 HEPATITIS TOXIC 2 0.0008
262 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
263 PULMONARY CONGESTION 10 0.0008
264 FURUNCLE 6 0.0008
265 APATHY 11 0.0008
266 HYPERPHAGIA 3 0.0008
267 ANGIONEUROTIC OEDEMA 2 0.0007
268 DELIRIUM 26 0.0007
269 INTENTIONAL OVERDOSE 48 0.0007
270 ORTHOSTATIC HYPOTENSION 13 0.0007
271 ANAESTHETIC COMPLICATION 2 0.0007
272 BRUXISM 4 0.0007
273 RESPIRATORY DEPRESSION 9 0.0007
274 SUICIDAL BEHAVIOUR 3 0.0007
275 RHABDOMYOLYSIS 30 0.0007
276 AGGRESSION 36 0.0007
277 ELECTRIC SHOCK SENSATION 2 0.0007
278 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
279 PSYCHOTIC DISORDER 21 0.0007
280 AGITATION 52 0.0007
281 SINUS TACHYCARDIA 10 0.0007
282 SHOULDER OPERATION 3 0.0007
283 HORDEOLUM 3 0.0007
284 HALLUCINATION, AUDITORY 11 0.0007
285 COMA SCALE ABNORMAL 2 0.0007
286 BLOOD SODIUM DECREASED 13 0.0007
287 METABOLIC DISORDER 4 0.0007
288 EXTRAPYRAMIDAL DISORDER 17 0.0007
289 INITIAL INSOMNIA 7 0.0007
290 CREPITATIONS 2 0.0007
291 CARDIO-RESPIRATORY ARREST 28 0.0007
292 EMERGENCY CARE 2 0.0007
293 DEPRESSED LEVEL OF CONSCIOUSNESS 26 0.0007
294 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
295 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
296 SEDATION 17 0.0006
297 BRAIN DEATH 2 0.0006
298 DELUSION 10 0.0006
299 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
300 BRAIN OEDEMA 8 0.0006
301 PULSE ABSENT 3 0.0006
302 BLOOD ALBUMIN DECREASED 5 0.0006
303 SLEEP APNOEA SYNDROME 12 0.0006
304 SCREAMING 4 0.0006
305 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
306 DIPLOPIA 16 0.0006
307 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
308 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
309 CONVULSION 35 0.0006
310 DIABETIC NEUROPATHY 3 0.0006
311 SPINAL COMPRESSION FRACTURE 5 0.0006
312 PROTEIN URINE PRESENT 3 0.0006
313 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
314 BLOOD UREA INCREASED 10 0.0006
315 DYSPHORIA 3 0.0006
316 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
317 SUBARACHNOID HAEMORRHAGE 6 0.0006
318 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
319 ECCHYMOSIS 4 0.0006
320 DISORIENTATION 23 0.0006
321 DROOLING 4 0.0006
322 MYOPATHY 5 0.0006
323 PETECHIAE 6 0.0006
324 FORMICATION 4 0.0006
325 SOMNOLENCE 115 0.0006
326 NYSTAGMUS 3 0.0006
327 OBESITY 9 0.0006
328 FRUSTRATION 2 0.0006
329 FACIAL BONES FRACTURE 2 0.0006
330 ABNORMAL BEHAVIOUR 22 0.0006
331 ERYTHEMA OF EYELID 3 0.0006
332 MENTAL DISORDER 24 0.0006
333 IRRITABILITY 33 0.0005
334 RENAL FAILURE ACUTE 23 0.0005
335 ALCOHOL USE 2 0.0005
336 FREEZING PHENOMENON 2 0.0005
337 DISTURBANCE IN ATTENTION 29 0.0005
338 HYPERACUSIS 2 0.0005
339 MENTAL IMPAIRMENT 13 0.0005
340 METABOLIC ACIDOSIS 17 0.0005
341 HEPATIC NECROSIS 2 0.0005
342 GENERALISED ERYTHEMA 3 0.0005
343 MYOCARDIAL ISCHAEMIA 6 0.0005
344 FACE INJURY 2 0.0005
345 NEUROLOGICAL SYMPTOM 3 0.0005
346 HYPERSOMNIA 15 0.0005
347 VISUAL DISTURBANCE 3 0.0005
348 DISSOCIATION 4 0.0005
349 SHOCK 12 0.0005
350 HYPERVENTILATION 3 0.0005
351 SINUS BRADYCARDIA 5 0.0005
352 FAECES HARD 2 0.0005
353 HYPERTRIGLYCERIDAEMIA 3 0.0005
354 TREATMENT NONCOMPLIANCE 28 0.0005
355 RENAL TUBULAR NECROSIS 5 0.0005
356 ASPARTATE AMINOTRANSFERASE INCREASED 27 0.0005
357 DRUG ERUPTION 9 0.0005
358 HAEMATOCRIT DECREASED 10 0.0005
359 PROTHROMBIN TIME PROLONGED 3 0.0005
360 HYPOTONIA 5 0.0005
361 TREMOR 83 0.0005
362 CANDIDIASIS 2 0.0005
363 MIOSIS 4 0.0005
364 TYPE 1 DIABETES MELLITUS 3 0.0005
365 TENSION 3 0.0005
366 DYSKINESIA 20 0.0005
367 DECUBITUS ULCER 4 0.0005
368 SLUGGISHNESS 5 0.0005
369 GOITRE 2 0.0005
370 CARDIOMEGALY 6 0.0005
371 GENERALISED OEDEMA 6 0.0005
372 SCOLIOSIS 3 0.0005
373 TACHYCARDIA 43 0.0005
374 OLIGURIA 3 0.0005
375 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
376 HEPATIC STEATOSIS 9 0.0005
377 HEPATIC FUNCTION ABNORMAL 18 0.0005
378 HYPONATRAEMIA 27 0.0005
379 HALLUCINATIONS, MIXED 2 0.0005
380 TOXICITY TO VARIOUS AGENTS 80 0.0005
381 FEELING JITTERY 9 0.0005
382 HEPATIC CYTOLYSIS 6 0.0005
383 CIRCULATORY COLLAPSE 8 0.0005
384 PANIC ATTACK 17 0.0005
385 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
386 ANURIA 4 0.0005
387 HYPERPROLACTINAEMIA 3 0.0005
388 HEPATIC LESION 2 0.0005
389 COMA 22 0.0005
390 PHARYNGITIS STREPTOCOCCAL 5 0.0005
391 EPILEPSY 14 0.0005
392 URINE OUTPUT DECREASED 4 0.0005
393 SOMNAMBULISM 3 0.0005
394 SPINAL OSTEOARTHRITIS 4 0.0005
395 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
396 HEAD DISCOMFORT 8 0.0005
397 PRODUCT SUBSTITUTION ISSUE 26 0.0005
398 POST-TRAUMATIC STRESS DISORDER 3 0.0004
399 WRONG PRODUCT ADMINISTERED 3 0.0004
400 HYPERHIDROSIS 57 0.0004
401 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
402 FEELING OF DESPAIR 2 0.0004
403 MIDDLE INSOMNIA 8 0.0004
404 HALLUCINATION, VISUAL 9 0.0004
405 UNRESPONSIVE TO STIMULI 11 0.0004
406 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
407 COLITIS MICROSCOPIC 2 0.0004
408 DEPRESSION 96 0.0004
409 ATAXIA 5 0.0004
410 GASTRIC ULCER 8 0.0004
411 URINARY RETENTION 14 0.0004
412 PARALYSIS 6 0.0004
413 FAECAL INCONTINENCE 2 0.0004
414 PANIC REACTION 3 0.0004
415 HEPATITIS C 5 0.0004
416 NO THERAPEUTIC RESPONSE 5 0.0004
417 SYNCOPE 41 0.0004
418 ENCEPHALOPATHY 10 0.0004
419 HYPERNATRAEMIA 2 0.0004
420 RESPIRATORY ARREST 11 0.0004
421 HEART RATE DECREASED 14 0.0004
422 DYSARTHRIA 15 0.0004
423 CORONARY ARTERY STENOSIS 2 0.0004
424 DRUG ABUSE 33 0.0004
425 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
426 HAEMATEMESIS 10 0.0004
427 DYSLIPIDAEMIA 2 0.0004
428 HAEMODYNAMIC INSTABILITY 3 0.0004
429 AMMONIA INCREASED 2 0.0004
430 THIRST 7 0.0004
431 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
432 NEUTROPHIL COUNT INCREASED 4 0.0004
433 FEMORAL NECK FRACTURE 2 0.0004
434 ANXIETY 111 0.0004
435 ATRIOVENTRICULAR BLOCK 3 0.0004
436 INFUSION SITE PAIN 5 0.0004
437 CONCUSSION 3 0.0004
438 APHTHOUS ULCER 3 0.0004
439 APNOEA 3 0.0004
440 VENTRICULAR EXTRASYSTOLES 4 0.0004
441 ANGER 13 0.0004
442 PULMONARY HAEMORRHAGE 3 0.0004
443 LOSS OF CONSCIOUSNESS 49 0.0004
444 FOOD CRAVING 2 0.0004
445 PULMONARY OEDEMA 17 0.0004
446 INCONTINENCE 4 0.0004
447 SUDDEN DEATH 4 0.0004
448 EATING DISORDER 8 0.0004
449 THINKING ABNORMAL 7 0.0004
450 FEAR 10 0.0004
451 JAUNDICE 10 0.0004
452 MUSCLE TIGHTNESS 6 0.0004
453 BEHAVIOUR DISORDER 2 0.0004
454 HYPOKALAEMIA 17 0.0004
455 TACHYPNOEA 5 0.0004
456 POLYURIA 3 0.0004
457 INCREASED APPETITE 7 0.0004
458 HICCUPS 3 0.0004
459 AUTISM SPECTRUM DISORDER 2 0.0004
460 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
461 DYSTONIA 7 0.0004
462 EOSINOPHIL COUNT INCREASED 3 0.0004
463 STEVENS-JOHNSON SYNDROME 8 0.0004
464 INTRACRANIAL PRESSURE INCREASED 2 0.0004
465 BRADYCARDIA 19 0.0004
466 CRYING 13 0.0004
467 C-REACTIVE PROTEIN INCREASED 13 0.0004
468 ACUTE PULMONARY OEDEMA 2 0.0004
469 THERAPY NON-RESPONDER 16 0.0004
470 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
471 DERMATITIS CONTACT 4 0.0004
472 MICTURITION URGENCY 4 0.0003
473 NIGHTMARE 12 0.0003
474 CARDIAC MURMUR 3 0.0003
475 SEXUAL DYSFUNCTION 4 0.0003
476 DEPRESSED MOOD 18 0.0003
477 LYMPHOCYTE COUNT DECREASED 6 0.0003
478 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
479 DECREASED INTEREST 2 0.0003
480 ACCIDENT 4 0.0003
481 WITHDRAWAL SYNDROME 14 0.0003
482 GASTROENTERITIS VIRAL 6 0.0003
483 OROPHARYNGEAL DISCOMFORT 3 0.0003
484 LEUKOCYTOSIS 6 0.0003
485 INSOMNIA 88 0.0003
486 HYPOGLYCAEMIA 16 0.0003
487 RETCHING 7 0.0003
488 TYPE 2 DIABETES MELLITUS 11 0.0003
489 MUSCLE SPASTICITY 4 0.0003
490 EMOTIONAL DISORDER 10 0.0003
491 MENTAL STATUS CHANGES 9 0.0003
492 CONJUNCTIVITIS 6 0.0003
493 DRUG EXPOSURE DURING PREGNANCY 11 0.0003
494 INFUSION SITE EXTRAVASATION 2 0.0003
495 HAEMATURIA 11 0.0003
496 PNEUMONIA ASPIRATION 8 0.0003
497 INFUSION SITE SWELLING 2 0.0003
498 POISONING DELIBERATE 3 0.0003
499 LETHARGY 18 0.0003
500 AFFECT LABILITY 3 0.0003
501 DIZZINESS POSTURAL 3 0.0003
502 HIATUS HERNIA 4 0.0003
503 AUTOIMMUNE DISORDER 3 0.0003
504 VITREOUS FLOATERS 3 0.0003
505 MUSCLE TWITCHING 7 0.0003
506 VENTRICULAR TACHYCARDIA 5 0.0003
507 APPETITE DISORDER 2 0.0003
508 BLOOD PRESSURE DECREASED 20 0.0003
509 DYSURIA 11 0.0003
510 HEPATIC FAILURE 9 0.0003
511 TOXIC SKIN ERUPTION 3 0.0003
512 EMPHYSEMA 3 0.0003
513 BRONCHITIS 22 0.0003
514 FACE OEDEMA 5 0.0003
515 HYPOTHERMIA 3 0.0003
516 PRODUCT TASTE ABNORMAL 4 0.0003
517 DRUG LEVEL DECREASED 3 0.0003
518 TOOTH ABSCESS 3 0.0003
519 IMPAIRED GASTRIC EMPTYING 4 0.0003
520 MOOD ALTERED 8 0.0003
521 LIVER DISORDER 13 0.0003
522 EYE MOVEMENT DISORDER 2 0.0003
523 CROHN'S DISEASE 2 0.0003
524 EYE DISCHARGE 3 0.0003
525 LARGE INTESTINE PERFORATION 2 0.0003
526 ORAL DISCOMFORT 4 0.0003
527 COORDINATION ABNORMAL 4 0.0003
528 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
529 APHONIA 4 0.0003
530 EXTRASYSTOLES 2 0.0003
531 CEREBRAL INFARCTION 7 0.0003
532 SPEECH DISORDER 15 0.0003
533 DRUG WITHDRAWAL SYNDROME 25 0.0003
534 BLOOD TEST ABNORMAL 4 0.0003
535 HYPOXIA 10 0.0003
536 TARDIVE DYSKINESIA 8 0.0003
537 DUODENAL ULCER 2 0.0003
538 RED BLOOD CELL COUNT DECREASED 8 0.0003
539 CONDITION AGGRAVATED 85 0.0003
540 IMPAIRED QUALITY OF LIFE 4 0.0003
541 OVERDOSE 60 0.0003
542 AMNESIA 18 0.0003
543 DERMATITIS BULLOUS 2 0.0003
544 LIVER FUNCTION TEST ABNORMAL 8 0.0003
545 RESTLESS LEGS SYNDROME 5 0.0003
546 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
547 GASTROENTERITIS 4 0.0003
548 ASPIRATION 3 0.0003
549 ACCIDENTAL OVERDOSE 10 0.0003
550 CARDIOMYOPATHY 4 0.0003
551 RASH GENERALISED 7 0.0003
552 HAEMATOMA 7 0.0003
553 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
554 ARTHROPOD BITE 2 0.0003
555 NERVOUSNESS 14 0.0003
556 SKIN INFECTION 3 0.0003
557 HYDRONEPHROSIS 2 0.0003
558 GASTRITIS 7 0.0003
559 POLLAKIURIA 11 0.0003
560 MYOCARDITIS 3 0.0003
561 ACIDOSIS 2 0.0003
562 INSURANCE ISSUE 4 0.0003
563 THYROID DISORDER 4 0.0003
564 FOOD ALLERGY 2 0.0003
565 HERNIA 5 0.0003
566 CONGENITAL ANOMALY 2 0.0003
567 ELECTROLYTE IMBALANCE 3 0.0003
568 NERVOUS SYSTEM DISORDER 8 0.0003
569 CHOKING 5 0.0003
570 SKIN FISSURES 5 0.0003
571 LYMPHADENOPATHY 9 0.0003
572 SEPTIC SHOCK 11 0.0003
573 HEAD INJURY 8 0.0003
574 HEART RATE INCREASED 25 0.0003
575 HALLUCINATION 19 0.0003
576 BLOOD PRESSURE ABNORMAL 5 0.0003
577 HYPERLIPIDAEMIA 3 0.0003
578 DIABETIC KETOACIDOSIS 6 0.0002
579 PREGNANCY 5 0.0002
580 DIABETES MELLITUS 19 0.0002
581 FRUSTRATION TOLERANCE DECREASED 2 0.0002
582 VERTIGO 15 0.0002
583 INTENTIONAL DOSE OMISSION 7 0.0002
584 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
585 BODY TEMPERATURE INCREASED 5 0.0002
586 BLOOD CREATININE INCREASED 16 0.0002
587 HYPOTENSION 49 0.0002
588 SMALL INTESTINAL OBSTRUCTION 3 0.0002
589 SPINAL OPERATION 3 0.0002
590 RIB FRACTURE 5 0.0002
591 TENDON RUPTURE 3 0.0002
592 HYPERCALCAEMIA 3 0.0002
593 CYST 3 0.0002
594 ILEUS 3 0.0002
595 COAGULOPATHY 4 0.0002
596 DYSSTASIA 7 0.0002
597 TINNITUS 11 0.0002
598 POISONING 3 0.0002
599 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
600 INFUSION SITE ERYTHEMA 2 0.0002
601 URINARY INCONTINENCE 7 0.0002
602 INADEQUATE ANALGESIA 2 0.0002
603 PYREXIA 81 0.0002
604 MEDICATION ERROR 13 0.0002
605 NECK PAIN 13 0.0002
606 PULMONARY EMBOLISM 22 0.0002
607 PRURITUS GENERALISED 5 0.0002
608 SWELLING FACE 15 0.0002
609 PLATELET COUNT INCREASED 3 0.0002
610 CONFUSIONAL STATE 37 0.0002
611 INTERSTITIAL LUNG DISEASE 11 0.0002
612 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
613 SWOLLEN TONGUE 7 0.0002
614 PANCREATITIS ACUTE 5 0.0002
615 BLOOD BILIRUBIN INCREASED 6 0.0002
616 DRY MOUTH 18 0.0002
617 HEART RATE IRREGULAR 5 0.0002
618 OEDEMA 12 0.0002
619 HEPATIC ENZYME INCREASED 15 0.0002
620 LEUKOPENIA 11 0.0002
621 HYPERGLYCAEMIA 8 0.0002
622 RESPIRATORY FAILURE 16 0.0002
623 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
624 HUNGER 3 0.0002
625 DEMENTIA 6 0.0002
626 ERYTHEMA MULTIFORME 2 0.0002
627 HEPATIC ENCEPHALOPATHY 2 0.0002
628 APPENDICITIS 2 0.0002
629 CHILLS 25 0.0002
630 LACERATION 2 0.0002
631 STAPHYLOCOCCAL INFECTION 7 0.0002
632 SEASONAL ALLERGY 3 0.0002
633 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
634 FRACTURE 4 0.0002
635 FOOT FRACTURE 4 0.0002
636 CARDIOGENIC SHOCK 3 0.0002
637 LOCALISED INFECTION 5 0.0002
638 CARDIAC ARREST 17 0.0002
639 FIBROMYALGIA 5 0.0002
640 OEDEMA PERIPHERAL 25 0.0002
641 HAEMORRHOIDS 4 0.0002
642 ORAL HERPES 4 0.0002
643 MEMORY IMPAIRMENT 28 0.0002
644 HEPATOMEGALY 2 0.0002
645 ACUTE MYOCARDIAL INFARCTION 6 0.0002
646 KNEE OPERATION 2 0.0002
647 HOSPICE CARE 2 0.0002
648 SINUS DISORDER 4 0.0002
649 BLADDER DISORDER 2 0.0002
650 WEIGHT INCREASED 45 0.0002
651 RESPIRATORY DISORDER 6 0.0002
652 ADVERSE DRUG REACTION 18 0.0002
653 ABORTION SPONTANEOUS 8 0.0002
654 HYPERKALAEMIA 7 0.0002
655 BLOOD POTASSIUM DECREASED 6 0.0002
656 BRAIN INJURY 2 0.0002
657 HYPOAESTHESIA ORAL 3 0.0002
658 APHASIA 6 0.0002
659 SLEEP DISORDER 14 0.0002
660 FEEDING DISORDER 4 0.0002
661 PALPITATIONS 23 0.0002
662 ERECTILE DYSFUNCTION 5 0.0002
663 LIMB DISCOMFORT 6 0.0002
664 TENDONITIS 3 0.0002
665 EJECTION FRACTION DECREASED 3 0.0002
666 DIZZINESS 96 0.0002
667 PRODUCT USE COMPLAINT 3 0.0002
668 DYSPHAGIA 18 0.0002
669 DISEASE RECURRENCE 9 0.0002
670 RESPIRATORY TRACT CONGESTION 3 0.0002
671 ABSCESS 3 0.0002
672 EAR INFECTION 5 0.0002
673 HYPOTHYROIDISM 6 0.0002
674 JOINT INJURY 4 0.0002
675 HYPOAESTHESIA 28 0.0002
676 MOVEMENT DISORDER 6 0.0002
677 POOR QUALITY SLEEP 4 0.0002
678 PRODUCT DISPENSING ERROR 4 0.0002
679 LUNG DISORDER 9 0.0002
680 FEELING ABNORMAL 44 0.0002
681 MULTIPLE FRACTURES 3 0.0002
682 BLOOD GLUCOSE FLUCTUATION 2 0.0002
683 PHOTOSENSITIVITY REACTION 3 0.0002
684 RESPIRATORY DISTRESS 5 0.0002
685 ABNORMAL DREAMS 5 0.0002
686 LIP SWELLING 6 0.0002
687 HYPERTENSIVE CRISIS 2 0.0002
688 CONSTIPATION 39 0.0002
689 RENAL IMPAIRMENT 15 0.0002
690 INTESTINAL PERFORATION 2 0.0002
691 BLOOD CALCIUM DECREASED 2 0.0002
692 FALL 59 0.0002
693 EYE INFECTION 2 0.0002
694 PAIN IN JAW 5 0.0002
695 HAEMOGLOBIN DECREASED 18 0.0002
696 SCAR 3 0.0002
697 ILLNESS 18 0.0002
698 MULTI-ORGAN FAILURE 3 0.0002
699 PNEUMONIA 56 0.0002
700 DECREASED APPETITE 40 0.0002
701 EYELID OEDEMA 2 0.0002
702 BLOOD CHOLESTEROL INCREASED 8 0.0002
703 COGNITIVE DISORDER 8 0.0002
704 EOSINOPHILIA 3 0.0002
705 VOMITING 80 0.0002
706 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
707 BLOOD IRON DECREASED 2 0.0002
708 BACTERAEMIA 2 0.0002
709 ASTHMA 19 0.0002
710 BLOOD PRESSURE FLUCTUATION 4 0.0002
711 COMPLICATION OF DEVICE REMOVAL 3 0.0002
712 PARAESTHESIA 26 0.0002
713 BURSITIS 2 0.0002
714 PRESYNCOPE 4 0.0002
715 NAUSEA 130 0.0002
716 DISCOMFORT 10 0.0002
717 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
718 ABNORMAL WEIGHT GAIN 2 0.0002
719 GYNAECOMASTIA 5 0.0002
720 AGRANULOCYTOSIS 3 0.0002
721 INJECTION SITE DISCOLOURATION 2 0.0002
722 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
723 HEPATIC CIRRHOSIS 3 0.0002
724 DRUG-INDUCED LIVER INJURY 5 0.0002
725 MUSCULAR WEAKNESS 18 0.0002
726 BLOOD URINE PRESENT 3 0.0002
727 NASOPHARYNGITIS 29 0.0002
728 HEPATITIS 4 0.0002
729 DRUG PRESCRIBING ERROR 3 0.0002
730 ACUTE RESPIRATORY FAILURE 3 0.0002
731 GLAUCOMA 3 0.0002
732 NIGHT SWEATS 5 0.0002
733 PRESCRIBED OVERDOSE 3 0.0002
734 LACTIC ACIDOSIS 5 0.0002
735 ASTHENIA 58 0.0002
736 KIDNEY INFECTION 3 0.0002
737 ECZEMA 8 0.0002
738 ANHEDONIA 4 0.0002
739 BEDRIDDEN 2 0.0002
740 ANKYLOSING SPONDYLITIS 2 0.0002
741 CHEST PAIN 28 0.0002
742 ERYTHEMA 31 0.0002
743 PRESCRIBED UNDERDOSE 3 0.0002
744 VIRAL INFECTION 5 0.0002
745 PLATELET COUNT DECREASED 16 0.0001
746 DEHYDRATION 20 0.0001
747 HEADACHE 94 0.0001
748 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
749 MALAISE 65 0.0001
750 ARRHYTHMIA 7 0.0001
751 BONE MARROW FAILURE 3 0.0001
752 NEUTROPHIL COUNT DECREASED 6 0.0001
753 SEIZURE 17 0.0001
754 PALLOR 4 0.0001
755 MIGRAINE 14 0.0001
756 SINUSITIS 15 0.0001
757 UNEVALUABLE EVENT 11 0.0001
758 BLOOD PRESSURE INCREASED 22 0.0001
759 ACUTE KIDNEY INJURY 22 0.0001
760 KNEE ARTHROPLASTY 3 0.0001
761 DRY SKIN 19 0.0001
762 DYSPEPSIA 14 0.0001
763 DIALYSIS 2 0.0001
764 IRRITABLE BOWEL SYNDROME 3 0.0001
765 PRODUCT QUALITY ISSUE 19 0.0001
766 CELLULITIS 7 0.0001
767 BALANCE DISORDER 12 0.0001
768 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
769 HYPOKINESIA 2 0.0001
770 BACK PAIN 32 0.0001
771 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
772 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
773 MUSCULOSKELETAL STIFFNESS 12 0.0001
774 HYPERTENSION 29 0.0001
775 COVID-19 24 0.0001
776 ABDOMINAL PAIN UPPER 28 0.0001
777 GAIT DISTURBANCE 26 0.0001
778 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
779 TRANSAMINASES INCREASED 3 0.0001
780 RASH MACULO-PAPULAR 3 0.0001
781 HEPATOTOXICITY 3 0.0001
782 RENAL INJURY 4 0.0001
783 COLON CANCER 2 0.0001
784 THROMBOCYTOPENIA 15 0.0001
785 GLOSSODYNIA 3 0.0001
786 RASH PAPULAR 3 0.0001
787 HAEMORRHAGE INTRACRANIAL 2 0.0001
788 THROAT IRRITATION 6 0.0001
789 MUSCULOSKELETAL PAIN 7 0.0001
790 PREMATURE BABY 4 0.0001
791 PANCREATITIS 7 0.0001
792 PRODUCT AVAILABILITY ISSUE 3 0.0001
793 HIP ARTHROPLASTY 2 0.0001
794 MYALGIA 22 0.0001
795 FEMUR FRACTURE 4 0.0001
796 RASH PRURITIC 7 0.0001
797 RENAL FAILURE 17 0.0001
798 CYANOSIS 2 0.0001
799 OCULAR HYPERAEMIA 6 0.0001
800 PRODUCT PRESCRIBING ERROR 3 0.0001
801 INFLUENZA 14 0.0001
802 SEPSIS 14 0.0001
803 MOOD SWINGS 4 0.0001
804 CONTUSION 12 0.0001
805 OXYGEN SATURATION DECREASED 7 0.0001
806 INFECTION 18 0.0001
807 DRUG INTOLERANCE 12 0.0001
808 ATRIAL FIBRILLATION 12 0.0001
809 OSTEOPOROSIS 5 0.0001
810 ABASIA 3 0.0001
811 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
812 INFUSION RELATED REACTION 8 0.0001
813 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
814 EPISTAXIS 9 0.0001
815 SKIN DISORDER 4 0.0001
816 MUSCLE SPASMS 22 0.0001
817 PRURITUS 46 0.0001
818 ROAD TRAFFIC ACCIDENT 5 0.0001
819 SURGERY 7 0.0001
820 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
821 OROPHARYNGEAL PAIN 11 0.0001
822 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
823 CHRONIC KIDNEY DISEASE 9 0.0001
824 PRODUCT COMPLAINT 3 0.0001
825 HEMIPARESIS 2 0.0001
826 OSTEOARTHRITIS 5 0.0001
827 CHEST DISCOMFORT 12 0.0001
828 GASTRIC DISORDER 4 0.0001
829 AMENORRHOEA 2 0.0001
830 FATIGUE 88 0.0001
831 ISCHAEMIC STROKE 2 0.0001
832 CARDIAC FAILURE CONGESTIVE 9 0.0001
833 ABDOMINAL PAIN 26 0.0001
834 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
835 DRUG INEFFECTIVE 147 0.0001
836 HOSPITALISATION 17 0.0001
837 LIMB INJURY 3 0.0001
838 NEUTROPENIA 15 0.0001
839 ANAEMIA 21 0.0001
840 UNDERDOSE 8 0.0001
841 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
842 SKIN DISCOLOURATION 5 0.0001
843 RHINORRHOEA 7 0.0001
844 FEELING COLD 3 0.0001
845 PANCYTOPENIA 6 0.0001
846 BACTERIAL INFECTION 2 0.0001
847 COUGH 30 0.0001
848 DIARRHOEA 69 0.0001
849 CARDIAC DISORDER 10 0.0001
850 EYE PAIN 6 0.0001
851 HYPOCALCAEMIA 2 0.0001
852 URINARY TRACT INFECTION 18 0.0001
853 COLITIS 4 0.0001
854 RASH ERYTHEMATOUS 5 0.0001
855 CHOLESTASIS 2 0.0001
856 BLOOD GLUCOSE DECREASED 5 0.0001
857 EAR PAIN 2 0.0001
858 BONE PAIN 6 0.0001
859 ASCITES 3 0.0001
860 PRODUCT DOSE OMISSION ISSUE 30 0.0001
861 ABDOMINAL DISCOMFORT 17 0.0001
862 WHEEZING 6 0.0001
863 DISABILITY 2 0.0001
864 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
865 CATARACT 6 0.0001
866 WEIGHT DECREASED 28 0.0001
867 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
868 CORONARY ARTERY DISEASE 3 0.0001
869 PSORIATIC ARTHROPATHY 4 0.0001
870 DEVICE BREAKAGE 4 0.0001
871 DYSPNOEA 55 0.0001
872 RASH 42 0.0001
873 PAIN 59 0.0001
874 INTENTIONAL DRUG MISUSE 2 0.0001
875 DERMATITIS ATOPIC 5 0.0001
876 VISION BLURRED 13 0.0001
877 CYSTITIS 3 0.0001
878 IMPAIRED WORK ABILITY 2 0.0001
879 OFF LABEL USE 81 0.0001
880 ALOPECIA 18 0.0001
881 INTENTIONAL PRODUCT MISUSE 8 0.0001
882 ANGIOEDEMA 4 0.0001
883 FUNGAL INFECTION 3 0.0001
884 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
885 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
886 FLATULENCE 5 0.0001
887 CARDIAC FAILURE 7 0.0001
888 HERPES ZOSTER 5 0.0001
889 THROMBOSIS 7 0.0001
890 ARTHRALGIA 36 0.0001
891 ABDOMINAL DISTENSION 9 0.0001
892 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
893 NASAL CONGESTION 5 0.0001
894 PAIN IN EXTREMITY 25 0.0001
895 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
896 CEREBRAL HAEMORRHAGE 3 0.0001
897 PRODUCTIVE COUGH 4 0.0001
898 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
899 URTICARIA 14 0.0001
900 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
901 SKIN EXFOLIATION 7 0.0001
902 DRUG EFFECT INCOMPLETE 3 0.0001
903 THERAPEUTIC RESPONSE DECREASED 5 0.0001
904 PLEURAL EFFUSION 5 0.0001
905 DYSGEUSIA 6 0.0001
906 EYE SWELLING 3 0.0001
907 AGEUSIA 2 0.0001
908 GASTRIC CANCER 2 0.0001
909 FLUID RETENTION 4 0.0001
910 INJECTION SITE SWELLING 6 0.0001
911 HYPOPHAGIA 2 0.0001
912 GASTROINTESTINAL DISORDER 7 0.0001
913 THERAPY CESSATION 4 0.0001
914 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
915 INFLAMMATION 4 0.0001
916 DEEP VEIN THROMBOSIS 5 0.0001
917 DEAFNESS 2 0.0001
918 JOINT STIFFNESS 2 0.0001
919 HYPERSENSITIVITY 14 0.0001
920 BREAST CANCER FEMALE 2 0.0001
921 SWELLING 7 0.0001
922 DRUG DEPENDENCE 12 0.0001
923 JOINT SWELLING 9 0.0001
924 PRODUCT USE ISSUE 14 0.0001
925 EMOTIONAL DISTRESS 9 0.0001
926 FREQUENT BOWEL MOVEMENTS 2 0.0001
927 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
928 HAEMATOCHEZIA 4 0.0001
929 DIVERTICULITIS 2 0.0001
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
931 BLISTER 4 0.0001
932 INJURY 5 0.0001
933 INCORRECT DOSE ADMINISTERED 16 0.0001
934 ANGINA PECTORIS 2 0.0001
935 MOBILITY DECREASED 5 0.0001
936 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
937 DYSPHONIA 4 0.0001
938 STOMATITIS 4 0.0001
939 ILL-DEFINED DISORDER 4 0.0001
940 DRUG ADMINISTRATION ERROR 2 0.0001
941 RENAL DISORDER 3 0.0001
942 EXPOSURE DURING PREGNANCY 4 0.0001
943 NEUROPATHY PERIPHERAL 6 0.0001
944 MULTIPLE SCLEROSIS 3 0.0001
945 HIP FRACTURE 2 0.0001
946 CHOLELITHIASIS 2 0.0001
947 IMPAIRED HEALING 2 0.0001
948 FEBRILE NEUTROPENIA 4 0.0001
949 DRY EYE 3 0.0001
950 GAIT INABILITY 2 0.0001
951 VISUAL IMPAIRMENT 7 0.0001
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
953 DRUG EFFECT DECREASED 3 0.0001
954 INJECTION SITE PAIN 17 0.0001
955 DRUG DOSE OMISSION 9 0.0001
956 DYSPNOEA EXERTIONAL 2 0.0001
957 HOT FLUSH 4 0.0001
958 INTESTINAL OBSTRUCTION 2 0.0001
959 RHEUMATOID ARTHRITIS 6 0.0001
960 EYE IRRITATION 3 0.0001
961 DISEASE PROGRESSION 6 0.0001
962 INJECTION SITE BRUISING 4 0.0001
963 PROSTATE CANCER 4 0.0000
964 EXTRA DOSE ADMINISTERED 2 0.0000
965 FLUSHING 5 0.0000
966 FEELING HOT 3 0.0000
967 INJECTION SITE ERYTHEMA 6 0.0000
968 HAEMORRHAGE 5 0.0000
969 HYPOACUSIS 2 0.0000
970 PRODUCT STORAGE ERROR 4 0.0000
971 INJECTION SITE PRURITUS 3 0.0000
972 BURNING SENSATION 3 0.0000
973 THERAPY INTERRUPTED 3 0.0000
974 INJECTION SITE HAEMORRHAGE 3 0.0000
975 BLOOD GLUCOSE INCREASED 7 0.0000
976 INFLUENZA LIKE ILLNESS 3 0.0000
977 TREATMENT FAILURE 3 0.0000
978 ANAPHYLACTIC REACTION 2 0.0000
979 DEATH 31 0.0000
980 ARTHROPATHY 2 0.0000
981 ADVERSE EVENT 3 0.0000
982 DEVICE EXPULSION 2 0.0000
983 PSORIASIS 4 0.0000
984 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
986 INJECTION SITE REACTION 2 0.0000
987 MYOCARDIAL INFARCTION 5 0.0000
988 PERIPHERAL SWELLING 4 0.0000
989 DEVICE ISSUE 2 0.0000
990 BREAST CANCER 2 0.0000
991 CEREBROVASCULAR ACCIDENT 3 0.0000
992 NO ADVERSE EVENT 3 0.0000